Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia
暂无分享,去创建一个
K. Wobbe | D. Coen | D. Knipe | J. Jacobson | K. Ruffner | C. B. Hwang | M. Kosz-Vnenchak
[1] D. Coen,et al. Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons , 1993, Journal of virology.
[2] K. Wobbe,et al. Unusual regulation of expression of the herpes simplex virus DNA polymerase gene , 1993, Journal of virology.
[3] J. D. Karkas,et al. Assessment of a selective inhibitor of herpes simplex virus thymidine kinase (L-653,180) as therapy for experimental recurrent genital herpes , 1992, Antimicrobial Agents and Chemotherapy.
[4] C. Crumpacker,et al. Resistance of herpesviruses to antiviral drugs , 1992, Antimicrobial Agents and Chemotherapy.
[5] B. Keith,et al. Regulation of herpes simplex virus true late gene expression: sequences downstream from the US11 TATA box inhibit expression from an unreplicated template , 1991, Journal of virology.
[6] Y. Cheng,et al. Suppression of ocular herpes recurrences by a thymidine kinase inhibitor in squirrel monkeys. , 1991, Antiviral research.
[7] D. Coen,et al. Polymerization activity of an alpha-like DNA polymerase requires a conserved 3'-5' exonuclease active site , 1991, Molecular and cellular biology.
[8] I. Duncan,et al. Design of Inhibitors of Herpes Simplex Virus Thymidine Kinase , 1991 .
[9] K. Steffy,et al. Upstream promoter elements of the herpes simplex virus type 1 glycoprotein H gene , 1991, Journal of virology.
[10] A. Papavassiliou,et al. Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly , 1991, Journal of virology.
[11] D. Coen,et al. Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses , 1990, Journal of virology.
[12] S. Czelusniak,et al. Effect of a thymidine kinase inhibitor (L-653,180) on antiviral treatment of experimental herpes simplex virus infection in mice. , 1990, Antiviral research.
[13] D. Coen,et al. Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants , 1990, Journal of virology.
[14] B. Roizman,et al. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus). , 1990, The Journal of infectious diseases.
[15] J. D. Karkas,et al. Suppression of herpes simplex virus type 1 reactivation from latency by (+-)-9-([(Z)-2-(hydroxymethyl)cyclohexyl]methyl) guanine (L-653,180) in vitro , 1990, Antimicrobial Agents and Chemotherapy.
[16] P. Schaffer,et al. Specific inhibitors of herpes simplex virus thymidine kinase diminish reactivation of latent virus from explanted murine ganglia , 1990, Antimicrobial Agents and Chemotherapy.
[17] H. Balfour,et al. Herpes Simplex Virus Resistant to Acyclovir: A Study in a Tertiary Care Center , 1990 .
[18] K. Tyler,et al. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity? , 1989, Annals of internal medicine.
[19] R. Sandri-Goldin,et al. Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus , 1989, Journal of virology.
[20] K. Tyler,et al. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Tenser,et al. Latency-associated transcript but not reactivatable virus is present in sensory ganglion neurons after inoculation of thymidine kinase-negative mutants of herpes simplex virus type 1 , 1989, Journal of virology.
[22] A. Minson,et al. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. , 1989, The Journal of general virology.
[23] D. Coen,et al. A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture , 1989, Journal of virology.
[24] K. Tyler,et al. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency , 1989, Journal of virology.
[25] D. Coen,et al. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model. , 1989, Virology.
[26] E. Mocarski,et al. Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse. , 1988, Virology.
[27] R. Longnecker,et al. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents. , 1988, The Journal of infectious diseases.
[28] R. Tenser,et al. Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation , 1987, Journal of virology.
[29] R. Everett,et al. The control of herpes simplex virus type-1 late gene transcription: a 'TATA-box'/cap site region is sufficient for fully efficient regulated activity. , 1986, Nucleic acids research.
[30] F. Homa,et al. Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA , 1986, Molecular and cellular biology.
[31] R. Tenser,et al. Thymidine kinase (TK) activity in herpes simplex virus type 1 recombinants that carry insertions affecting regulation of the TK gene. , 1986, Virology.
[32] S. McKnight,et al. A genetic approach to promoter recognition during trans induction of viral gene expression. , 1986, Science.
[33] B. Roizman,et al. Establishment of latency in mice by herpes simplex virus 1 recombinants that carry insertions affecting regulation of the thymidine kinase gene , 1985, Journal of virology.
[34] D. Coen,et al. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus , 1985, Journal of virology.
[35] J. Bienenstock,et al. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2 , 1984, Journal of virology.
[36] R. Price,et al. Resistance of peripheral autonomic neurons to in vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity , 1981, Infection and immunity.
[37] R. Tenser,et al. Herpes simplex virus thymidine kinase expression in trigeminal ganglion infection: correlation of enzyme activity with ganglion virus titer and evidence of in vivo complementation. , 1981, Virology.
[38] S. Mackem,et al. Regulation of α genes of herpes simplex virus: Expression of chimeric genes produced by fusion of thymidine kinase with α gene promoters , 1981, Cell.
[39] J. Clements,et al. The association of herpes simplex virus with squamous carcinoma of the cervix, and studies of the virus thymidine kinase gene , 1980, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[40] R. Tenser,et al. Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion. , 1979, Virology.
[41] S. Bacchetti,et al. Selective assay for herpes simplex viruses expressing thymidine kinase , 1979, Journal of virology.
[42] P. Schaffer,et al. Collaborative complementation study of temperature-sensitive mutants of herpes simplex virus types 1 and 2 , 1978, Journal of virology.
[43] K. Nadeau,et al. The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[44] R. Tenser. Role of herpes simplex virus thymidine kinase expression in viral pathogenesis and latency. , 1991, Intervirology.
[45] I. Duncan,et al. New Potent and Selective Inhibitors of Herpes Simplex Virus Tbyhidine Kinase , 1989 .
[46] V. Rich. Personal communication , 1989, Nature.
[47] R. Longnecker,et al. Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1. , 1988, Virology.
[48] B. Roizman,et al. An inquiry into the mechanisms of herpes simplex virus latency. , 1987, Annual review of microbiology.